GLP-1RAs and SGLT2is Reduce Cardiovascular Events Independent of Reductions of Systolic Blood Pressure and Body Weight: A Meta-Analysis with Meta-Regression

Introduction The impact of reduction of systolic blood pressure or body weight on reduction of cardiovascular events during the treatment with glucagon-like peptide 1 receptor agonists (GLP-1RAs) or sodium-glucose cotransporter 2 inhibitors (SGLT2is) for type 2 diabetes is unclear. Methods We search...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes therapy 2020-10, Vol.11 (10), p.2429-2440
Hauptverfasser:	Qiu, Mei, Ding, Liang-Liang, Zhang, Miao, Lin, Jin-Hao, Wei, Xu-Bin, Huang, Hua
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood pressure Body weight Brief Report Cardiology Cardiovascular disease Diabetes Drug therapy Endocrinology GLP-1 receptor agonists Hypoglycemic agents Internal Medicine Medicine Medicine & Public Health Meta-analysis Type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!